Roche Applies To Market Covid Antibody Treatment In EU
Mohammad Ali (@ChaudhryMAli88) Published October 11, 2021 | 09:30 PM
The Hague, (UrduPoint / Pakistan Point News - 11th Oct, 2021 ) :Swiss pharma giant Roche on Monday applied to market its anti-Covid-19 cocktail in the European Union, the bloc's medicines watchdog said, the final step before it can be released to the continent.
The application to the European Medicines Agency comes just over two weeks after the World Health Organisation also recommended the treatment, which Roche co-developed with US biotech firm Regeneron.
The "EMA is starting evaluating an application for marketing authorisation for the monoclonal antibody combination Ronapreve (casirivimab/imdevimab)," the Amsterdam-based watchdog said.
A speeded-up process means the EMA "could issue an opinion within two months," it added.
Monoclonal antibodies -- which recognise a specific molecule of the target virus or bacteria -- are synthetic copies of those natural proteins that can be reproduced and administered as a treatment.
This is different from a vaccine, which stimulates the body to produce its own immune response.
Synthetic antibodies are administered to people already infected, to make up for deficiencies in the immune system.
Ronapreve "is intended for the treatment of Covid-19 in adults and adolescents from 12 years of age who do not require supplemental oxygen therapy" and risked getting a severe form of the disease.
It is also used "for the prevention of Covid-19 in adults and adolescents aged 12 and older," the EMA said.
Designed by Regeneron and marketed by Roche, Ronapreve treatment was given to former US president Donald Trump during his brush with coronavirus.
An application for marketing authorisation is the last stage in which the EMA's human medicines committee does a final scientific evaluation before making a recommendation to the European Commission, who can then give its release the thumbs-up.
Two weeks ago the WHO also backed the treatment but only in patients with specific health profiles.
Persons with non-severe Covid-19 who are nonetheless at high risk of hospitalisation can take the antibodies, as should critically ill patients unable to mount an adequate immune response, the WHO said in a finding published in the BMJ.
The cocktail is only the third treatment for Covid recommended by the global health authority.
So far, the only treatment authorised for use in Europe is remdesivir, marketed as Veklury, a so-called viral RNA polymerase inhibitor which interferes with the production of viral genetic material, preventing the virus from multiplying inside cells.
Related Topics
Recent Stories
ICC Womens T20 World Cup Qualifier, Match 2: Ireland Women open with Comfortable ..
Robinson, bowlers help New Zealand go 2-1 up against Pakistan
Shahzeb Chachar to hold khuli kachehri on April 26
Heatwave amid Israel's aggression in Gaza brings new misery, disease risk
Tourism must change, mayor says as Venice launches entry fee
Court adjourns Judicial Complex attack case till May 17
Nasreen Noori’s book ‘Popatan Jahra Khwab’ launched
Wafaqi Mohtasib inspection team visits Excise and taxation office
AJLAC announces 5th Conference titled ‘People’s Mandate: Safeguarding Civil ..
Pak-US officials engage to enhance trade, investment ties
IBCC to promote educational excellence, expand regional presence
Pakistani 'Blue Helmets' serving UN Peacekeeping Mission in DR Congo set to leav ..
More Stories From Miscellaneous
-
PDMA predicts gusty wind, rain with thunder, hails
2 days ago -
Iranian president Raisi given guard of honour at PM House
4 days ago -
Intellectuals, writers accolades Naseer Mirza on his literary contribution
4 days ago -
Bahawalpur Adabi Sangat hosts memorable mushaira
5 days ago -
Cattle farming vital to alleviate poverty in rural areas
5 days ago -
Pakistan: A land of tourism, archeological wonders
5 days ago
-
Transforming education sector: from job hunters to job creators
7 days ago -
Amjad Bobby remembered on 19th death anniversary for timeless contributions to music
11 days ago -
Legendary actor Nadeem’s 26 films released on Eid-ul-Fitr days in 50 years
11 days ago -
Besant Hall Cultural Centre to celebrate evening with Sanam Marvi on 26 April
12 days ago -
Radio Bahawalpur presents program “Eidi Shidi”
15 days ago -
Radio Bahawalpur to broadcast Eid programs
17 days ago